Header Logo

Connection

Bruce Fireman to Hospitalization

Back to Details
This is a "connection" page, showing publications Bruce Fireman has written about Hospitalization.
Bruce Fireman
Connection Strength
2.381
Hospitalization
  1. Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022. MMWR Morb Mortal Wkly Rep. 2022 Feb 18; 71(7):255-263.
    View in: PubMed
    Score: 0.540
  2. Effect of influenza vaccination on hospitalizations in persons aged 50 years and older. Vaccine. 2010 Oct 21; 28(45):7267-72.
    View in: PubMed
    Score: 0.244
  3. Respiratory syncytial virus (RSV) vaccine effectiveness against RSV-associated hospitalisations and emergency department encounters among adults aged 60 years and older in the USA, October, 2023, to March, 2024: a test-negative design analysis. Lancet. 2024 Oct 19; 404(10462):1547-1559.
    View in: PubMed
    Score: 0.162
  4. Incidence and Risk of Coronavirus Disease 2019 Hospitalization Among Unvaccinated Children. Influenza Other Respir Viruses. 2024 Oct; 18(10):e70022.
    View in: PubMed
    Score: 0.162
  5. Influenza Vaccine Effectiveness Against Influenza A-Associated Emergency Department, Urgent Care, and Hospitalization Encounters Among US Adults, 2022-2023. J Infect Dis. 2024 Jul 25; 230(1):141-151.
    View in: PubMed
    Score: 0.160
  6. Estimates of Bivalent mRNA Vaccine Durability in Preventing COVID-19-Associated Hospitalization and Critical Illness Among Adults with and Without Immunocompromising Conditions - VISION Network, September 2022-April 2023. MMWR Morb Mortal Wkly Rep. 2023 May 26; 72(21):579-588.
    View in: PubMed
    Score: 0.147
  7. Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19-Associated Hospitalizations Among Immunocompromised Adults - Nine States, January-September 2021. MMWR Morb Mortal Wkly Rep. 2021 Nov 05; 70(44):1553-1559.
    View in: PubMed
    Score: 0.132
  8. Risk for Hospitalized Heart Failure Among New Users of Saxagliptin, Sitagliptin, and Other Antihyperglycemic Drugs: A Retrospective Cohort Study. Ann Intern Med. 2016 Jun 07; 164(11):705-14.
    View in: PubMed
    Score: 0.090
  9. Implementation of an outpatient electronic health record and emergency department visits, hospitalizations, and office visits among patients with diabetes. JAMA. 2013 Sep 11; 310(10):1060-5.
    View in: PubMed
    Score: 0.075
  10. Interim Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19-Associated Hospitalization Among Adults Aged =18 Years with Immunocompromising Conditions - VISION Network, September 2023-February 2024. MMWR Morb Mortal Wkly Rep. 2024 Mar 28; 73(12):271-276.
    View in: PubMed
    Score: 0.039
  11. Interim Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalization Among Immunocompetent Adults Aged =18 Years - VISION and IVY Networks, September 2023-January 2024. MMWR Morb Mortal Wkly Rep. 2024 Feb 29; 73(8):180-188.
    View in: PubMed
    Score: 0.039
  12. Recombinant or Standard-Dose Influenza Vaccine in Adults under 65 Years of Age. N Engl J Med. 2023 Dec 14; 389(24):2245-2255.
    View in: PubMed
    Score: 0.038
  13. Estimates of Bivalent mRNA Vaccine Durability in Preventing COVID-19-Associated Hospitalization and Critical Illness Among Adults with and Without Immunocompromising Conditions - VISION Network, September 2022-April 2023. Am J Transplant. 2023 07; 23(7):1062-1076.
    View in: PubMed
    Score: 0.037
  14. Effectiveness of COVID-19 vaccines at preventing emergency department or urgent care encounters and hospitalizations among immunocompromised adults: An observational study of real-world data across 10 US states from August-December 2021. Vaccine. 2023 08 23; 41(37):5424-5434.
    View in: PubMed
    Score: 0.037
  15. Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults - VISION Network, Nine States, September-November 2022. MMWR Morb Mortal Wkly Rep. 2023 Mar 17; 71(53):1637-1646.
    View in: PubMed
    Score: 0.036
  16. Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults - VISION Network, Nine States, September-November 2022. MMWR Morb Mortal Wkly Rep. 2022 Dec 30; 71(5152):1616-1624.
    View in: PubMed
    Score: 0.036
  17. Effectiveness of COVID-19 mRNA Vaccines Against COVID-19-Associated Hospitalizations Among Immunocompromised Adults During SARS-CoV-2 Omicron Predominance - VISION Network, 10 States, December 2021-August 2022. MMWR Morb Mortal Wkly Rep. 2022 Oct 21; 71(42):1335-1342.
    View in: PubMed
    Score: 0.035
  18. Adults hospitalized with breakthrough COVID-19 have lower mortality than matched unvaccinated adults. J Intern Med. 2022 Aug; 292(2):377-384.
    View in: PubMed
    Score: 0.034
  19. Effectiveness of Homologous and Heterologous COVID-19 Booster Doses Following 1 Ad.26.COV2.S (Janssen [Johnson & Johnson]) Vaccine Dose Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults - VISION Network, 10 States, December 2021-March 2022. MMWR Morb Mortal Wkly Rep. 2022 Apr 01; 71(13):495-502.
    View in: PubMed
    Score: 0.034
  20. Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5-17 Years - VISION Network, 10 States, April 2021-January 2022. MMWR Morb Mortal Wkly Rep. 2022 Mar 04; 71(9):352-358.
    View in: PubMed
    Score: 0.034
  21. Effectiveness of two-dose vaccination with mRNA COVID-19 vaccines against COVID-19-associated hospitalizations among immunocompromised adults-Nine States, January-September 2021. Am J Transplant. 2022 01; 22(1):306-314.
    View in: PubMed
    Score: 0.033
  22. Laboratory-Confirmed COVID-19 Among Adults Hospitalized with COVID-19-Like Illness with Infection-Induced or mRNA Vaccine-Induced SARS-CoV-2 Immunity - Nine States, January-September 2021. MMWR Morb Mortal Wkly Rep. 2021 Nov 05; 70(44):1539-1544.
    View in: PubMed
    Score: 0.033
  23. Live Attenuated Influenza Vaccination Before 3 Years of Age and Subsequent Development of Asthma: A 14-year Follow-up Study. Pediatr Infect Dis J. 2018 05; 37(5):383-386.
    View in: PubMed
    Score: 0.026
  24. Cost of care for cancer in a health maintenance organization. Health Care Financ Rev. 1997; 18(4):51-76.
    View in: PubMed
    Score: 0.024
  25. Impact of vaccination on the epidemiology of varicella: 1995-2009. Pediatrics. 2014 Jul; 134(1):24-30.
    View in: PubMed
    Score: 0.020
  26. Adverse clinical events among medicare beneficiaries using antipsychotic drugs: linking health insurance benefits and clinical needs. Med Care. 2013 Jul; 51(7):614-21.
    View in: PubMed
    Score: 0.019
  27. Evaluation of immunization rates and safety among children with inborn errors of metabolism. Pediatrics. 2011 May; 127(5):e1139-46.
    View in: PubMed
    Score: 0.016
  28. A survival analysis of hospitalization among patients with acquired immunodeficiency syndrome. Am J Public Health. 1989 Dec; 79(12):1643-7.
    View in: PubMed
    Score: 0.014
  29. Risk adjusting community-acquired pneumonia hospital outcomes using automated databases. Am J Manag Care. 2008 Mar; 14(3):158-66.
    View in: PubMed
    Score: 0.013
  30. Risk of suicide attempt and suicide death in patients treated for bipolar disorder. Bipolar Disord. 2007 Aug; 9(5):526-30.
    View in: PubMed
    Score: 0.012
  31. Cost-sharing for emergency care and unfavorable clinical events: findings from the safety and financial ramifications of ED copayments study. Health Serv Res. 2006 Oct; 41(5):1801-20.
    View in: PubMed
    Score: 0.012
  32. Multiphasic Health Checkup Evaluation: a 16-year follow-up. J Chronic Dis. 1986; 39(6):453-63.
    View in: PubMed
    Score: 0.011
  33. Observed costs and health care use of children in a randomized controlled trial of pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2002 May; 21(5):361-5.
    View in: PubMed
    Score: 0.009
  34. Alcohol drinking patterns and medical care use in an HMO setting. J Behav Health Serv Res. 2000 Feb; 27(1):3-16.
    View in: PubMed
    Score: 0.007
  35. The impact of aging and chronic disease on use of hospital and outpatient services in a large HMO: 1971-1991. J Am Geriatr Soc. 1997 Jun; 45(6):667-74.
    View in: PubMed
    Score: 0.006
  36. Alcohol use and medical care utilization among health maintenance organization patients in the emergency department. Acad Emerg Med. 1996 Feb; 3(2):106-13.
    View in: PubMed
    Score: 0.006
  37. Safety and immunogenicity of oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine in infancy. The Northern California Kaiser Permanente Vaccine Study Center Pediatrics Group. Pediatr Infect Dis J. 1991 Feb; 10(2):92-6.
    View in: PubMed
    Score: 0.004
  38. The cost of acquired immunodeficiency syndrome in northern California. The experience of a large prepaid health plan. Arch Intern Med. 1990 Apr; 150(4):833-8.
    View in: PubMed
    Score: 0.004

© 2024 Kaiser Permanente